Trials / Completed
CompletedNCT03261362
Impact of Branched-chain Amino Acids in the Development of Insulin Resistance
Branched-Chain Amino Acid Dietary Reduction Under Weight Maintainance in Overweight Patients With Type 2 Diabetes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- German Diabetes Center · Academic / Other
- Sex
- All
- Age
- 30 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to clarify the role of the branched-chain amino acids in the development of Insulin resistance in patients with diabetes
Detailed description
The proposed project aims to elucidate the role of the BCAA in the development of insulin resistance and type 2 diabetes. The project tests the hypothesis that a diet induced decrease of BCAAs concentrations alter the metabolic mechanisms involved in the control insulin resistance and diabetes progression. The specific aims are to elucidate the effect of the diet induced decrease of BCAAs concentrations on (I) peripheral and hepatic insulin sensitivity (II) ectopic fat distribution (III) energy metabolism (IV) metabolic and inflammatory status
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Branched-chain amino acids reduced intake |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2019-12-31
- Completion
- 2019-12-31
- First posted
- 2017-08-25
- Last updated
- 2023-06-05
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03261362. Inclusion in this directory is not an endorsement.